Ciluprevir

Ciluprevir
Clinical data
ATC code none
Legal status
Legal status
  • Investigational
Identifiers
CAS Number 300832-84-2
PubChem (CID) 9853710
ChemSpider 8029420
UNII 75C8DU40T0 YesY
ChEMBL CHEMBL297884
Chemical and physical data
Formula C40H50N6O8S
Molar mass 774.93 g/mol
3D model (Jmol) Interactive image

Ciluprevir is used experimentally in the treatment of hepatitis C. It is manufactured by Boehringer Ingelheim Pharma GmbH & Co. kg and developed under the research code of BILN-2061. It is targeted against NS2-3 protease.[1]

References

  1. Abbenante, G; Fairlie, DP (2005). "Protease inhibitors in the clinic". Medicinal chemistry. 1 (1): 71–104. doi:10.2174/1573406053402569. PMID 16789888.


This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.